메뉴 건너뛰기




Volumn 25, Issue 5, 2006, Pages 255-263

Construction and purification of a covalently linked divalent tandem single-chain Fv antibody against placental alkaline phosphatase

Author keywords

[No Author keywords available]

Indexed keywords

ACTEV PROTEASE; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; HYBRID PROTEIN; MONOCLONAL ANTIBODY H7; NICKEL; NITRILOTRIACETIC ACID; POLYHISTIDINE TAG; PROTEINASE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRXA PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; CARCINOPLACENTAL ISOENZYMES; ISOENZYME;

EID: 33947217939     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.25.255     Document Type: Article
Times cited : (6)

References (35)
  • 2
    • 0026327378 scopus 로고
    • Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
    • Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, and Schlom J: Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 1991;51:6363-6371.
    • (1991) Cancer Res , vol.51 , pp. 6363-6371
    • Milenic, D.E.1    Yokota, T.2    Filpula, D.R.3    Finkelman, M.A.4    Dodd, S.W.5    Wood, J.F.6    Whitlow, M.7    Snoy, P.8    Schlom, J.9
  • 5
    • 0033046339 scopus 로고    scopus 로고
    • Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody
    • Beresford GW, Pavlinkova G, Booth BJ, Batra SK, and Colcher D: Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody. Int J Cancer 1999;81: 911-917.
    • (1999) Int J Cancer , vol.81 , pp. 911-917
    • Beresford, G.W.1    Pavlinkova, G.2    Booth, B.J.3    Batra, S.K.4    Colcher, D.5
  • 6
    • 0032870332 scopus 로고    scopus 로고
    • Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts
    • Pavlinkova G, Beresford GW, Booth BJ, Batra SK, and Colcher D: Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts. J Nucl Med 1999;40:1536-1546.
    • (1999) J Nucl Med , vol.40 , pp. 1536-1546
    • Pavlinkova, G.1    Beresford, G.W.2    Booth, B.J.3    Batra, S.K.4    Colcher, D.5
  • 7
    • 0014943238 scopus 로고
    • Affinity and the immune response
    • Karush F: Affinity and the immune response. Ann NY Acad Sci 1970;169:56-64.
    • (1970) Ann NY Acad Sci , vol.169 , pp. 56-64
    • Karush, F.1
  • 8
    • 33644857036 scopus 로고    scopus 로고
    • Monospecific bivalent scFv-SH: Effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility
    • Albrecht H, Denardo GL, and Denardo SJ: Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility. J Immunol Methods 2006.
    • (2006) J Immunol Methods
    • Albrecht, H.1    Denardo, G.L.2    Denardo, S.J.3
  • 10
    • 0037436345 scopus 로고    scopus 로고
    • The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: Implications for diabody flexibility
    • Carmichael JA, Power BE, Garrett TP, Yazaki PJ, Shively JE, Raubischek AA, Wu AM, and Hudson PJ: The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility. J Mol Biol 2003;326:341-351.
    • (2003) J Mol Biol , vol.326 , pp. 341-351
    • Carmichael, J.A.1    Power, B.E.2    Garrett, T.P.3    Yazaki, P.J.4    Shively, J.E.5    Raubischek, A.A.6    Wu, A.M.7    Hudson, P.J.8
  • 11
    • 0028949091 scopus 로고
    • Tetravalent miniantibodies with high avidity assembling in Escherichia coli
    • Pack P, Muller K, Zahn R, and Pluckthun A: Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol 1995;246:28-34.
    • (1995) J Mol Biol , vol.246 , pp. 28-34
    • Pack, P.1    Muller, K.2    Zahn, R.3    Pluckthun, A.4
  • 12
    • 0034830739 scopus 로고    scopus 로고
    • Dimeric and trimeric antibodies: High avidity scFvs for cancer targeting
    • Kortt AA, Dolezal O, Power BE, and Hudson PJ: Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. Biomol Eng 2001;18:95-108.
    • (2001) Biomol Eng , vol.18 , pp. 95-108
    • Kortt, A.A.1    Dolezal, O.2    Power, B.E.3    Hudson, P.J.4
  • 13
    • 0027197493 scopus 로고
    • Diabodies: Small bivalent and bispecific antibody fragments
    • Holliger P, Prospero T, and Winter G: "Diabodies": Small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 1993;90:6444-6448.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 6444-6448
    • Holliger, P.1    Prospero, T.2    Winter, G.3
  • 14
    • 0030748513 scopus 로고    scopus 로고
    • Triabodies: Single chain Fv fragments without a linker form trivalent trimers
    • Iliades P, Kortt AA, and Hudson PJ: Triabodies: Single chain Fv fragments without a linker form trivalent trimers. FEBS Lett 1997;409:437-441.
    • (1997) FEBS Lett , vol.409 , pp. 437-441
    • Iliades, P.1    Kortt, A.A.2    Hudson, P.J.3
  • 15
    • 0029890636 scopus 로고    scopus 로고
    • Minibody: A novel engineered anticarcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts
    • Hu S, Shively L, Raubitschek A, Sherman M, Williams LE, Wong JY, Shively JE, and Wu AM: Minibody: A novel engineered anticarcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 1996;56:3055-3061.
    • (1996) Cancer Res , vol.56 , pp. 3055-3061
    • Hu, S.1    Shively, L.2    Raubitschek, A.3    Sherman, M.4    Williams, L.E.5    Wong, J.Y.6    Shively, J.E.7    Wu, A.M.8
  • 16
    • 0032403273 scopus 로고    scopus 로고
    • Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis
    • Reiter Y and Pastan I: Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. Trends Biotechnol 1998;16:513-520.
    • (1998) Trends Biotechnol , vol.16 , pp. 513-520
    • Reiter, Y.1    Pastan, I.2
  • 17
    • 33751017388 scopus 로고    scopus 로고
    • Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase
    • Sheikholvaezin A, Sandstrom P, Eriksson D, Norgren N, Riklund K, and Stigbrand T: Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase. Hybridoma 2006;25:181-192.
    • (2006) Hybridoma , vol.25 , pp. 181-192
    • Sheikholvaezin, A.1    Sandstrom, P.2    Eriksson, D.3    Norgren, N.4    Riklund, K.5    Stigbrand, T.6
  • 18
    • 0020508096 scopus 로고
    • Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies
    • Millan JL and Stigbrand T: Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem 1983;136:1-7.
    • (1983) Eur J Biochem , vol.136 , pp. 1-7
    • Millan, J.L.1    Stigbrand, T.2
  • 19
    • 0031740502 scopus 로고    scopus 로고
    • Differences in sequence and affinity between three monoclonal anti-idiotypic antibodies against one anti-placental alkaline phosphatase idiotypic antibody
    • Sandstrom PJA, Ullen A, Behravan G, and Stigbrand T: Differences in sequence and affinity between three monoclonal anti-idiotypic antibodies against one anti-placental alkaline phosphatase idiotypic antibody. Tumor Targeting 1998;3:80-86.
    • (1998) Tumor Targeting , vol.3 , pp. 80-86
    • Sandstrom, P.J.A.1    Ullen, A.2    Behravan, G.3    Stigbrand, T.4
  • 20
    • 0003046374 scopus 로고    scopus 로고
    • Producing antibodies in Escherichia coli: From PCR to fermentation
    • McCafferty J, Hoogenboom HR, and Chiswell DJ Eds, IRL Press, Oxford
    • Pluckthun A KA, Krebber C, Horn U, Knupfer U, Wenderoth R, Nieba L, Proba K, and Riesenberg D: Producing antibodies in Escherichia coli: From PCR to fermentation. In: Antibody Engineering. McCafferty J, Hoogenboom HR, and Chiswell DJ (Eds.). IRL Press, Oxford, 1996, pp. 203-252.
    • (1996) Antibody Engineering , pp. 203-252
    • Pluckthun, A.K.1    Krebber, C.2    Horn, U.3    Knupfer, U.4    Wenderoth, R.5    Nieba, L.6    Proba, K.7    Riesenberg, D.8
  • 21
    • 0014949207 scopus 로고
    • Cleavage of structural proteins during the assembly of the head of bacteriophage T4
    • Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
    • (1970) Nature , vol.227 , pp. 680-685
    • Laemmli, U.K.1
  • 24
    • 0028140247 scopus 로고
    • Construction, expression, and activity of a bivalent bispecific single-chain antibody
    • Mallender WD and Voss EW, Jr.: Construction, expression, and activity of a bivalent bispecific single-chain antibody. J Biol Chem 1994;269:199-206.
    • (1994) J Biol Chem , vol.269 , pp. 199-206
    • Mallender, W.D.1    Voss Jr., E.W.2
  • 25
    • 0025978976 scopus 로고
    • Man-made antibodies
    • Winter G and Milstein C: Man-made antibodies. Nature 1991;349: 293-299.
    • (1991) Nature , vol.349 , pp. 293-299
    • Winter, G.1    Milstein, C.2
  • 26
    • 0021832361 scopus 로고
    • Hybrid antibodies can target sites for attack by T cells
    • Staerz UD, Kanagawa O, and Bevan MJ: Hybrid antibodies can target sites for attack by T cells. Nature 1985;314:628-631.
    • (1985) Nature , vol.314 , pp. 628-631
    • Staerz, U.D.1    Kanagawa, O.2    Bevan, M.J.3
  • 27
    • 0023126589 scopus 로고
    • The use of hybrid hybridomas to target human cytotoxic T lymphocytes
    • Lanzavecchia A and Scheidegger D: The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur J Immunol 1987;17:105-111.
    • (1987) Eur J Immunol , vol.17 , pp. 105-111
    • Lanzavecchia, A.1    Scheidegger, D.2
  • 28
    • 0030738617 scopus 로고    scopus 로고
    • New protein engineering approaches to multivalent and bispecific antibody fragments
    • Pluckthun A and Pack P: New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology 1997;3:83-105.
    • (1997) Immunotechnology , vol.3 , pp. 83-105
    • Pluckthun, A.1    Pack, P.2
  • 29
    • 0026772358 scopus 로고
    • Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate
    • Cumber AJ, Ward ES, Winter G, Parnell GD, and Wawrzynczak EJ: Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J Immunol 1992;149:120-126.
    • (1992) J Immunol , vol.149 , pp. 120-126
    • Cumber, A.J.1    Ward, E.S.2    Winter, G.3    Parnell, G.D.4    Wawrzynczak, E.J.5
  • 30
    • 0028302596 scopus 로고
    • Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli
    • Gruber M, Schodin BA, Wilson ER, and Kranz DM: Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J Immunol 1994;152:5368-5374.
    • (1994) J Immunol , vol.152 , pp. 5368-5374
    • Gruber, M.1    Schodin, B.A.2    Wilson, E.R.3    Kranz, D.M.4
  • 31
    • 0028236196 scopus 로고
    • Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system
    • Hayden MS, Linsley PS, Gayle MA, Bajorath J, Brady WA, Norris NA, Fell HP, Ledbetter JA, and Gilliland LK: Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system. Ther Immunol 1994;1:3-15.
    • (1994) Ther Immunol , vol.1 , pp. 3-15
    • Hayden, M.S.1    Linsley, P.S.2    Gayle, M.A.3    Bajorath, J.4    Brady, W.A.5    Norris, N.A.6    Fell, H.P.7    Ledbetter, J.A.8    Gilliland, L.K.9
  • 33
    • 0029932582 scopus 로고    scopus 로고
    • Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody
    • Holliger P, Brissinck J, Williams RL, Thielemans K, and Winter G: Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng 1996;9:299-305.
    • (1996) Protein Eng , vol.9 , pp. 299-305
    • Holliger, P.1    Brissinck, J.2    Williams, R.L.3    Thielemans, K.4    Winter, G.5
  • 35
    • 0022378268 scopus 로고
    • Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy
    • Larson SM: Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med 1985;26:538-545.
    • (1985) J Nucl Med , vol.26 , pp. 538-545
    • Larson, S.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.